A favorable outcome of intensive immunotherapies for new-onset refractory status epilepticus (NORSE)
Abstract Background New-onset refractory status epilepticus (NORSE) is a newly defined critical disease entity characterized by prolonged periods of refractory epileptic seizure with no readily identifiable cause in otherwise healthy individuals. Its etiology is uncertain, but autoimmune encephaliti...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | Journal of Intensive Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40560-018-0315-7 |